HYPOXIA ACTIVATED PRODRUGS AND MTOR INHIBITORS FOR TREATING CANCER
- 专利权人:
- 发明人:
- Charles Hart,Jessica Sun,Fanying Meng
- 申请号：
- US14367152
- 公开号：
- US20150005262A1
- 申请日:
- 2012.12.20
- 申请国别(地区):
- US
- 年份:
- 2015
- 代理人:
- 摘要：
- Cancer is treated by administration of a hypoxia activated prodrug in combination with an mTOR inhibitor.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Administration of hypoxia activated prodrug in combination with CHK1 inhibitor to treat cancer
- ADMINISTRATION OF HYPOXIA ACTIVATED PRODRUGS AND ANTIANGIOGENIC AGENTS FOR THE TREATMENT OF CANCER
- ADMINISTRATION OF HYPOXIA ACTIVATED PRODRUGS AND ANTIANGIOGENIC AGENTS FOR THE TREATMENT OF CANCER
- 암 치료를 위한 저산소증 활성 프로드러그와 항혈관형성제의 투여
- ADMINISTRATION OF HYPOXIA ACTIVATED PRODRUGS AND ANTIANGIOGENIC AGENTS FOR THE TREATMENT OF CANCER
